| ACT | adoptive cell therapy |
| CAR-T cell | chimeric antigen receptor T cell |
| GMP | good manufacture practice |
| DC | dendritic cell |
| EVA | ethyl vinyl acetate |
| FEP | fluorinated ethylene propylene |
| HFBR | hollow-fiber bioreactor |
| MSCs | mesenchymal stem cells |
| NK | natural killer |
| PBL | peripheral blood lymphocyte |
| PoC | point-of-care |
| TIL | tumor infiltrating lymphocyte |